Literature DB >> 27037180

Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló's concentric sclerosis.

Todd A Hardy1, W Oliver Tobin2, Claudia F Lucchinetti2.   

Abstract

The availability of magnetic resonance imaging (MRI) has led to increasing recognition that multiple sclerosis (MS), tumefactive demyelination (TD) and Baló's concentric sclerosis (BCS) share many overlapping features. Baló-like lesions, which exhibit limited features of BCS, may represent an intermediate between BCS and typical MS demyelination. Lesions labeled as tumefactive are typically larger, but otherwise have much in common with conventional MS lesions, and TD and BCS lesions can also overlap. In this article, we explore the similarities between typical MS, TD and BCS cases, and reflect on the potential insights that intermediate or overlapping phenotypes may contribute towards an understanding of MS immunopathogenesis, and question whether these atypical forms of demyelination should be classified as separate demyelinating diseases, as different lesional manifestations of demyelination of any cause or as part of a spectrum with conventional MS.
© The Author(s), 2016.

Entities:  

Keywords:  Histopathology; atypical; immunopathogenesis; newly forming; pseudotumor

Mesh:

Year:  2016        PMID: 27037180     DOI: 10.1177/1352458516641776

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  13 in total

1.  Sirt2 epigenetically down-regulates PDGFRα expression and promotes CG4 cell differentiation.

Authors:  Na Fang; Junjun Cheng; Chu Zhang; Keyuan Chen; Chenyu Zhang; Zichao Hu; Ran Bi; Kendra L Furber; Merlin Thangaraj; Adil J Nazarali; Shaoping Ji
Journal:  Cell Cycle       Date:  2019-05-10       Impact factor: 4.534

Review 2.  Multiple Sclerosis: Diagnosis and Differential Diagnosis.

Authors:  Sami Ömerhoca; Sinem Yazici Akkaş; Nilüfer Kale İçen
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

Review 3.  Pattern Recognition of the Multiple Sclerosis Syndrome.

Authors:  Rana K Zabad; Renee Stewart; Kathleen M Healey
Journal:  Brain Sci       Date:  2017-10-24

4.  Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.

Authors:  Matthew A Tremblay; Javier E Villanueva-Meyer; Soonmee Cha; Tarik Tihan; Jeffrey M Gelfand
Journal:  J Neurol Sci       Date:  2017-08-10       Impact factor: 3.181

5.  Clinical and Radiologic Features, Pathology, and Treatment of Baló Concentric Sclerosis.

Authors:  Evan A Jolliffe; Yong Guo; Todd A Hardy; P Pearse Morris; Eoin P Flanagan; Claudia F Lucchinetti; W Oliver Tobin
Journal:  Neurology       Date:  2021-05-19       Impact factor: 11.800

6.  Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature.

Authors:  Aigli G Vakrakou; Dimitrios Tzanetakos; Theodore Argyrakos; Georgios Koutsis; Maria-Eleptheria Evangelopoulos; Elisabeth Andreadou; Maria Anagnostouli; Marianthi Breza; John S Tzartos; Elias Gialafos; Antonios N Dimitrakopoulos; Georgios Velonakis; Panagiotis Toulas; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2020-06-30       Impact factor: 4.003

7.  7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions.

Authors:  Janina R Behrens; Julia Wanner; Joseph Kuchling; Lennard Ostendorf; Lutz Harms; Klemens Ruprecht; Thoralf Niendorf; Sven Jarius; Brigitte Wildemann; René M Gieß; Michael Scheel; Judith Bellmann-Strobl; Jens Wuerfel; Friedemann Paul; Tim Sinnecker
Journal:  Ann Clin Transl Neurol       Date:  2018-06-29       Impact factor: 4.511

Review 8.  Biomarkers in Rare Demyelinating Disease of the Central Nervous System.

Authors:  Marina Boziki; Styliani-Aggeliki Sintila; Panagiotis Ioannidis; Nikolaos Grigoriadis
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

9.  A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression.

Authors:  Yuri Nakamura; Laura Gaetano; Takuya Matsushita; Altermatt Anna; Till Sprenger; Ernst-Wilhelm Radue; Jens Wuerfel; Lorena Bauer; Michael Amann; Koji Shinoda; Noriko Isobe; Ryo Yamasaki; Takahiko Saida; Ludwig Kappos; Jun-Ichi Kira
Journal:  J Neuroinflammation       Date:  2018-09-05       Impact factor: 8.322

10.  Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases.

Authors:  Aigli G Vakrakou; Dimitrios Tzanetakos; Maria-Eleptheria Evangelopoulos; Theodore Argyrakos; John S Tzartos; Maria Anagnostouli; Elissavet Andreadou; Georgios Koutsis; Georgios Velonakis; Panagiotis Toulas; Elias Gialafos; Antonios Dimitrakopoulos; Erasmia Psimenou; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Ther Adv Neurol Disord       Date:  2021-05-18       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.